Proton NMR visible mobile lipid signals in sensitive and multidrug-resistant K562 cells are modulated by rafts by Mannechez, Aurélie et al.
BioMed  Central
C
TIONAL INTERNA
CANCER CELL
Page 1 of 10
(page number not for citation purposes)
Cancer Cell International
Open Access Primary research
Proton NMR visible mobile lipid signals in sensitive and 
multidrug-resistant K562 cells are modulated by rafts
Aurélie Mannechez1, Paiboon Reungpatthanaphong2, Jacques D de 
Certaines1, Geneviève Leray1 and Laurence Le Moyec*2
Address: 1Laboratoire de Résonance Magnétique en Biologie et Médecine, Université Rennes 1, avenue du Professeur Léon Bernard, 35043 
RENNES Cedex. France and 2Laboratoire LPBC-CSSB, UMR CNRS 7033, Université Paris 13, 74 avenue, Marcel Cachin, 93017 Bobigny Cedex. 
France
Email: Aurélie Mannechez - amannech@hotmail.com; Paiboon Reungpatthanaphong - bun_paiboon@msn.com; Jacques D de Certaines - jd.de-
certaines@rennes.fnclcc.fr; Geneviève Leray - genevieve.leray.1@univ-rennes1.fr; Laurence Le Moyec* - lemoyec@smbh.univ-paris13.fr
* Corresponding author    
Proton Magnetic Resonance SpectroscopyMultidrug resistanceMobile lipidsRafts
Abstract
Background: Most cancer cells are characterized by mobile lipids visible on proton NMR (1H-
NMR), these being comprised mainly of methyl and methylene signals from lipid acyl chains.
Erythroleukemia K562 cells show narrow signals at 1.3 and 0.9 ppm, corresponding to mobile lipids
(methylene and methyl, respectively), which are reduced when K562 cells are multidrug resistant
(MDR). While the significance of the mobile lipids is unknown, their subcellular localization is still
a matter of debate and may lie in the membrane or the cytoplasm. In this study, we investigate the
role of cholesterol in the generation of mobile lipid signals.
Results: The proportion of esterified cholesterol was found to be higher in K562-sensitive cells
than in resistant cells, while the total cholesterol content was identical in both cell lines.
Cholesterol extraction in the K562 wild type (K562wt) cell line and its MDR counterpart
(K562adr), using methyl-β-cyclodextrin, was accompanied by a rise of mobile lipids in K562wt cells
only. The absence of caveolae was checked by searching for the caveolin-1 protein in K562wt and
K562adr cells. However, cholesterol was enriched in another membrane microdomain designated
as "detergent-insoluble glycosphingomyelin complexes" or rafts. These microdomains were studied
after extraction with triton X-100, a mild non-ionic detergent, revealing mobile lipid signals
preserved only in the K562wt spectra. Moreover, following perturbation/disruption of these
microdomains using sphingomyelinase, mobile lipids increased only in K562wt cells.
Conclusion: These results suggest that cholesterol and sphingomyelin are involved in mobile lipid
generation via microdomains of detergent-insoluble glycosphingomyelin complexes such as rafts.
Increasing our knowledge of membrane microdomains in sensitive and resistant cell lines may open
up new possibilities in resistance reversion.
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Background
When studied by NMR proton spectroscopy, most cancer
cells are characterized by increased narrow signals at 0.9
and 1.3 ppm corresponding, respectively, to methyl and
methylene resonances that belong to lipid acyl chains
moving isotropically. This so-called "mobile lipid signal"
(or ML signal) has been studied for several decades (for
review see[1]). However, research has failed to elucidate
the molecular origin of mobile lipids, their subcellular
localization or their physiological significance.
Regarding their molecular origin, acyl chains can form
part of triglycerides or esterified cholesterol. Phospholip-
idic acyl chains may also be involved if they are not
embedded in membrane lipid bilayers. As far as localiza-
tion is concerned, two types of subcellular origin are still
debated. As early as 1988 [2], Mountford et al proposed
an origin in lipoprotein-like microdomains within the
plasma membrane. More recently, some authors [3] have
suggested the occurrence of cytosolic droplets, which
appear concomitantly with the ML in stressed cells [4] or
which are associated with necrosis [5] and apoptosis.
However, it has been shown that ML intensity is not
always correlated with the number of cytoplasmic drop-
lets [6]. These studies (op cit.) tend to show that cytosolic
lipid droplets generate mobile lipid signals in NMR spec-
tra, without excluding the possibility that such signals
could arise independently of the presence of cytosolic
lipid bodies.
1H-NMR spectroscopy shows that ML are decreased in
erythroleukemia K562 cells when these become resistant
(K562adr)[7], whereas the compositions of lipids
extracted from K562wt (drug sensitive) and K562adr cells
are the same, except for sphingomyelin content which is
increased in resistant cells [8]. Thus, although we may
explain this by a structural difference in lipid "organiza-
tion", the significance of such a behaviour is not yet eluci-
dated. In a previous study [9], we showed that the ML
signal is not linked to the externalization of phosphatidyl-
serine (a membrane phospholipid), this being a phenom-
ena that precedes apoptosis.
In model membranes, free cholesterol interacts with
phospholipids and sphingolipids to influence membrane
fluidity [10]. In vivo, cellular-free cholesterol is located in
the plasma membrane [11], which exhibits increasing
structural order as demonstrated in erythrocytes [12], LM
and CHO cells [13,14]. Moreover, cholesterol in model
membranes is able to promote microdomains towards an
intermediate state called the liquid-ordered phase (Lo),
with less fluidity than the gel phase state and more fluidity
than the surrounding membrane in the liquid crystalline
state [15].
The aim of this study was to investigate a possible contri-
bution from the cholesterol-containing membrane
domain to the ML detected in the NMR proton spectra of
wild-type K562 and K562 adriamycin-resistant cells.
In a first set of experiments, cell membrane cholesterol
was extracted by methyl-β-cyclodextrin (MCD). MCD is
an oligosaccharid able to pump cholesterol out of the cell
[16]. Moreover, cholesterol extracted by MCD originates
primarily from the plasma membrane [17]. Cell incuba-
tion with MCD was expected to change the membrane
microdomains via cholesterol extraction, and conse-
quently produce variations in ML. In a second set of exper-
iments, we used triton-X100 to separate membrane
microdomains and then investigated their role in ML gen-
eration. In this study, we use the term "Detergent Insolu-
ble Glycosphingolipid Complexes" (DIGCs) or "rafts" to
refer to the membrane microdomains isolated by treat-
ment with this mild non-ionic detergent (for review see
[18]). Finally, as these raft microdomains are also
enriched in sphingolipids, we used sphingomyelinase to
modify their "organization", with the aim of inducing
changes in ML signal intensity.
Results
Cholesterol quantification
K562wt and K562adr cells do not differ in their total cho-
lesterol contents. The proportion of cholesterol-ester were
found to be lower in the resistant cells than in the wild
type cells (Table 1). This implies that K562wt cells contain
more free cholesterol than K562adr cells. Total cholesterol
content after MCD treatment (Table 1) shows a 45 %
decrease in both K562wt and K562adr cells with respect to
the control.
Table 1: Quantification of cholesterol in K562 cells. Results are expressed as means ± SD.
K562 wt K562adr
Total cholesterol (µg/106 cells) 3.6 ± 0.5 (n = 5) 3.5 ± 0.3 (n = 4)
Cholesterol ester (percentage of total cholesterol) 26.5 ± 1.3 (n = 6) 19.4 ± 2.4 (n = 5)
Cholesterol variation with MCD treatment (% of control) 57 ± 13 (n = 5) 54 ± 15 (n = 4)Cancer Cell International 2005, 5:2 http://www.cancerci.com/content/5/1/2
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Cell proliferation after incubation with methyl-β-
cyclodextrin
The cell proliferation results for K562wt and K562adr are
presented in Figs. 1 and 2. The two-hour incubation with-
out FCS had no effect on proliferation in K562wt or
K562adr when compared to cells incubated in RPMI+FCS.
Treatment with MCD inhibited proliferation in K562wt.
This was not the case with K562adr, which grew normally.
When K562adr cells were resuspended in R10 containing
daunorubicin (0.25 nM), they were able to proliferate at
this daunorubicin concentration. However, after treat-
ment with MCD, the K562adr proliferation rate was
decreased as shown in figure 2. This shows that MCD
treatment reversed the resistance phenotype in K562adr;
despite having no effect on cell growth, MCD affected the
K562adr cell membrane.
Caveolin-1 expression: Western-Blot
Caveolin-1 expression was studied in K562 cells by SDS-
page and western-blotting. Caveolin-1 is a protein of 21
kD [19]. As a positive control, we chose a protein extract
of NIH-3T3 cells that are known to express caveolin-1. In
this control, a band appeared between the 19 and 32 kD
size markers. In the present study, however, neither
K562wt nor K562adr expressed caveolin-1.
1H-NMR spectra
Incubation with methyl-β-cyclodextrin
Figure 3 shows spectra obtained on K562wt and K562adr
cells, and resonance ratios are presented in Table 2. These
results show that MCD increases the lipid signals only in
K562wt cells. This increase can also be seen in Table 3,
which reports a significant increase of CH3/Ct and CH2/Ct
ratios in MCD-treated K562wt cells compared with non-
treated cells.
Triton X-100 and sphingomyelinase treatments
spectra obtained after treatments with PFA, triton and
sphingomyelinase are presented in Figures 4 and 5 for
K562wt and K562adr cells, respectively. The ratios of the
K562wt cells (up) and K562adr cells (down) were incubated  for 2 hours in medium alone (WT RPMI; full line and square,  n = 6) supplemented in FCS 10% (dot line and lozenge, WT  R10; n = 6), in methyl-β-cyclodextrin 5 mM (dot line and tri- angle, WT MCD; n = 6) and successively incubated in R10 for  72 hours Figure 1
K562wt cells (up) and K562adr cells (down) were incubated 
for 2 hours in medium alone (WT RPMI; full line and square, 
n = 6) supplemented in FCS 10% (dot line and lozenge, WT 
R10; n = 6), in methyl-β-cyclodextrin 5 mM (dot line and tri-
angle, WT MCD; n = 6) and successively incubated in R10 for 
72 hours. Data points are the percentages of the cellular 
concentration normalized to cellular concentration at T = 0 
hours expressed as means, with vertical bars representing 
standard deviation (SD).
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K562adr resistance modulation after MCD treatment Figure 2
K562adr resistance modulation after MCD treatment. 
K562adr cells were incubated for 2 hours in medium supple-
mented in SVF 10% (R10-DN; n = 4) or in methyl-β-cyclo-
dextrin 5 mM (CD-DN; n = 4) and seeded in R10 containing 
daunorubicin for 72 hours. Data points are the percentages 
of the cellular concentration normalized to cellular concen-
tration at T = 0 hours expressed as means, with vertical bars 
representing standard deviation (SD).
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peak intensities with respect to the creatine peak are
reported in Table 3. When compared to the control, PFA
treatment did not modify the cell spectra. After microdo-
main separation by triton treatment, the CH2/Ct ratio was
increased for K562wt cells and, to a lesser extent, for
K562adr cells. N-trimethyl to creatine peak ratios were
NMR proton spectra obtained at D3 on K562wt (left side) and K562adr (right side) on control cells (top spectra) or treated  with 5 mM MCD during 2 hours (bottom spectra) Figure 3
NMR proton spectra obtained at D3 on K562wt (left side) and K562adr (right side) on control cells (top spectra) or treated 
with 5 mM MCD during 2 hours (bottom spectra). Peak assignment – 1: CH3 from fatty acid chains; 2: CH2 from fatty acid 
chains; 3: Alanine; 4 : glutamine and glutamate; 5: creatine; 6 N-trimethyl from choline, 7: Inositol; 8 : CH2 in β position from 
ester function in fatty acid ester; 9: CH2 in a position of a double bond in fatty acids; 10 : CH2 in α position from ester function 
in fatty acid ester.
Table 2: NMR peak ratios measured on K562wt and K562adr spectra. Cells were incubated for 2 hours in RPMI, or in RPMI containing 
methyl-β-cyclodextrin 5 mM (MCD). Results are expressed as means of arbitrary units ± SD multiplied by tenStatistical analysis : *: P < 
0.05 when compared with RMPI incubated cells.
K562wt K562adr
Group RPMI (n = 6) MCD (n = 5) RPMI (n = 4) MCD (n = 4)
CH3/Ct 50 ± 5 101 ± 22* 34 ± 3 34 ± 2
CH2/Ct 247 ± 35 537 ± 13* 142 ± 22 130 ± 18
N+(CH3)3/Ct 23 ± 3 22 ± 7 17 ± 3 21 ± 16
1
2
3
4
5
6
7
(pp m )
0 .4 0 .8 1 .2 1 .6 2 .0 2 .4 2 .8 3 .2 3 .6 4 .0 4 .4
8
9
10
(ppm)
0.8 1.2 1.6 2.0 2.4 2.8 3.2 3.6 4.0 4.4Cancer Cell International 2005, 5:2 http://www.cancerci.com/content/5/1/2
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decreased in both cell lines. After treatment of these
microdomains with sphingomyelinase, the spectra
showed an increased CH2/Ct ratio compared with the pre-
vious spectrum obtained on "DIGCs" in K562wt cells.
However, the spectra of K562adr cells treated with Smase
remained unchanged compared with spectra obtained on
DIGCs from K562adr cells.
Discussion
We studied the modification of cell spectra using choles-
terol and sphingomyelin because: i) cholesterol levels
affect membrane fluidity; ii) membrane microdomains,
rafts and caveolae are all enriched in these lipids. Western-
blot did not detect the presence of caveolin-1 in either
K562wt or K562adr. This confirms previous results show-
ing the absence of caveolin-1 in K562wt [20]. Even if
membrane microdomains exist in this cellular type, this
implies they represent rafts and not caveolae.
Rafts have been described as corresponding to membrane
microdomains enriched in cholesterol and sphingomye-
lin lipids [18]. In our first set of experiments, we disrupted
the rafts using MCD to extract cholesterol from the cells.
Before MCD treatment, K562wt and K562adr cells dis-
played the same cholesterol concentrations, which were
found to be in agreement with previous results obtained
for other cancer cells [21,22]. In K562wt cells, this choles-
terol was preferentially in the form of cholesterol-ester,
implying that the absolute concentration of free choles-
terol is lower in K562wt cells compared with K562adr
cells. 90% of the free cholesterol is contained in plasma
membrane [11]. On the other hand, cholesterol-ester syn-
thesized in the endoplasmic reticulum is generally local-
ized in the cytosol and is able to form cytoplasmic lipid
bodies. This cholesterol is less available to MCD extrac-
tion. Thus, MCD treatment may affect the free-cholesterol
plasma membrane pool [17] and not the intracellular
pool that mainly contains cholesterol-ester in K562wt
cells. Consequently, in our study, a higher proportion of
membrane cholesterol (corresponding to free cholesterol)
was extracted in K562wt cells compared against K562adr
cells. This may account for the fact that the proliferation
rate for K562wt was more affected than for K562adr.
Moreover, the removal of a greater proportion of mem-
brane cholesterol modified the NMR proton spectra of the
cells, since the mobile lipid signals only increased in the
K562wt cells.
Nevertheless, we observe that MCD treatment affected the
K562adr cell line. This is demonstrated by the reversion of
daunorubicin resistance. In the plasma membrane,
K562adr cells express the P-gp glycoprotein responsible
for the extrusion of drugs. When K562adr cells were
treated with MCD, the resistance to daunorubicin was
decreased, showing that the P-gp is unable to extrude dau-
norubicin from the cells. P-gp has been widely reported to
be sensitive to the lipid content of plasma membrane
[23]. The present study shows that MDR is sensitive to the
cellular cholesterol content. Indeed, it has been shown
that drugs can accumulate in MDR cells grown in the pres-
ence of MCD [24].
This first set of experiments suggests that ML signals are
generated during the disruption of membrane microdo-
mains in K562wt cells, because MCD has been shown to
extract cholesterol preferentially from membrane micro-
domains [17]. Overall, these results tend to show a link
might exist between microdomains and the ML signal in
K562 cells.
In a second set of experiments, we isolated rafts using tri-
ton X-100 at 4°C, a mild detergent in which they are
insoluble [25]. We applied this method to K562wt and
K562adr cells. NMR spectra obtained on these isolated
raft fractions show an increase of the ML signals for
K562wt and K562adr cells. In this particular case, this
implies that ML could be produced by raft domains.
Although it has been shown that raft structures are tightly
Table 3: NMR peak ratios measured on K562wt and K562adr spectra. PBS: incubation in PBS; PFA: incubation in PFA; Triton : 
incubation in PFA and triton X; Smase: incubation in PFA, triton X-100 and 0.5 units sphingomyelinase. Results are expressed as 
means of arbitrary units ± SD multiplied by ten.
K562wt K562adr
Group PBS (n = 4) PFA (n = 7) Triton (n = 7) Smase (n = 4) PBS (n = 4) PFA (n = 7) Triton (n = 8) Smase (n = 5)
CH3/Ct 198 ± 21 231 ± 12 312 ± 42* 392 ± 105° 161 ± 19 192 ± 22 265 ± 62* 267 ± 42*
CH2/Ct 541 ± 52 611 ± 78 1060 ± 164* 1696 ± 441° 308 ± 93 386 ± 56 695 ± 141* 565 ± 167*
N(CH3)3/Ct 132 ± 6 141 ± 18 53 ± 10* 79 ± 17° 114 ± 12 132 ± 36 60 ± 15* 94 ± 39*
Statistical analysis : * : P < 0.05 when compared with PBS-incubated cells,
°: P < 0.05 when compared with Triton-treated cells,Cancer Cell International 2005, 5:2 http://www.cancerci.com/content/5/1/2
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packed at 4°C, there is no report of their ?organization/
structure at 25°C, which is the temperature chosen for the
NMR experiments [26]. At this temperature, microdo-
main lipids could be in another physical state allowing
them to move more isotropically and produce an NMR-
visible signal: their solubility in triton at 25°C supports
this hypothesis [27].
In the final set of experiments, we incubated detergent
insoluble fractions with sphingomyelinase, which was
K562wt 1H-NMR spectra: effects of Triton X-100 and sphingomyelinase treatments Figure 4
K562wt 1H-NMR spectra: effects of Triton X-100 and sphingomyelinase treatments. A: non-treated cells; B: cells fixed with 
PFA; C: cells fixed with PFA 4% in triton-X100 1%; D: cells fixed with PFA 4% incubated in triton-X100 1% and with 0.5 units 
sphingomyelinase. For peak assignment, see figure 4. Peaks at 3.6 ppm after SMase treatment arise from enzyme working 
buffer.
(ppm)
0.4 0.8 1.2 1.6 2.0 2.4 2.8 3.2 3.6 4.0
(ppm)
0.4 0.8 1.2 1.6 2.0 2.4 2.8 3.2 3.6 4.0
(ppm)
0.4 0.8 1.2 1.6 2.0 2.4 2.8 3.2 3.6 4.0
(ppm)
0.4 0.8 1.2 1.6 2.0 2.4 2.8 3.2 3.6 4.0
A.
B.
D.
C.Cancer Cell International 2005, 5:2 http://www.cancerci.com/content/5/1/2
Page 7 of 10
(page number not for citation purposes)
supposed to metabolise the sphingomyelin included in
the rafts. Only the K562wt spectra exhibited an increase in
ML signal compared with the raft spectra. Again, this
suggests that microdomains are differently organized
between K562wt and K562adr. Several hypotheses may be
proposed to explain the difference between K562wt and
K562adr: i) sphingomyelin concentrations are higher in
K562adr; ii) lipid microdomains in K562adr may be
organized in such a way that sphingomyelin is inaccessi-
ble to sphingomyelinase and iii) there are more microdo-
mains in K562adr, as suggested previously by some
authors [28].
Conclusions
These results suggest that, while isolated rafts generate ML
signals within the membrane, the presence of rafts seems
to maintain a relatively tight organization. When this
organized structure is disrupted by MCD or sphingomy-
elinase, the ML signal may be detected in K562wt cells and
the P-gp function can then be modulated in K562adr cells.
Taken together, the results suggest that ML signals may be
sensitive to modifications in the lipidic organization of
the cells and membrane, in which microdomains behave
as rafts enriched in cholesterol and sphingomyelin. A bet-
ter knowledge of these microdomains, as well as the dif-
K562adr 1H-NMR spectra: effects of Triton X-100 and sphingomyelinase treatments Figure 5
K562adr 1H-NMR spectra: effects of Triton X-100 and sphingomyelinase treatments. A: non-treated cells; B: cells fixed with 
PFA; C: cells fixed with PFA 4% in triton-X100 1%; D: cells fixed with PFA 4% incubated in triton-X100 1% and with 0.5 units 
sphingomyelinase. H-NMR spectra: Triton X-100 and sphingomyelinase treatment. For peak assignment, see Fig. 4. Peaks at 3.6 
ppm after SMase treatment arise from enzyme working buffer.
(ppm)
0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0
(ppm)
0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0
(ppm)
0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0
(ppm)
0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0
A.
B.
C.
D.Cancer Cell International 2005, 5:2 http://www.cancerci.com/content/5/1/2
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ferences in behaviour between sensitive and resistant
cells, could open up new therapeutic perspectives for
reversing the drug-resistance phenotype.
Materials and Methods
Chemicals
Methyl-β-cyclodextrin, sphingomyelinase, cholesterol,
chloroform, isopropanol and paraformaldehyde, as well
as deuterium oxide (D2O) and all chemicals for western-
blot analysis were provided by Sigma-Aldrich (Saint-
Quentin Fallavier, France). Triton X-100 was supplied by
Merck (Schuchardt, Darmstadt, Germany), and methanol
by Acros Organics (Geel, Belgium).
Cell culture
Human erythroleukemia K562 cells were grown in the
culture medium RPMI 1640 (Bio-Whittaker Europe, Verv-
iers, Belgium) supplemented with fœtal calf serum (FCS)
(10%) and glutamine (2 mM) (R10 medium) at 37°C
and 5 % CO2. The K562 resistant variant cells (K562adr)
were a gift from F. Calvo, Université Paris 7, and were
grown in the same medium with 0.5 µg/ml adriamycin.
Cholesterol quantification
Lipids were extracted as previously described [29], and
then desiccated and resuspended in isopropanol. Total
cholesterol and free cholesterol were assayed using a kit
(Cholesterol RTU, Biomérieux Craponne, and Boeringher,
France) based on cholesterol esterase. This was followed
by cholesterol oxidase reaction and colour development
measured on an absorption spectrometer at 500 nm. Con-
centration was determined using a standard solution of
0.5 mg/ml cholesterol. We first checked that the solvent
(isopropanol or chloroform) did not have any effect on
colour development.
Cholesterol extraction using methyl-β-cyclodextrin
Cells were incubated in RPMI, glutamin 2 mM, containing
methyl-β-cyclodextrin 5 mM for 2 hours at 37°C, 5%
CO2. Controls were incubated in RPMI, glutamin 2 mM,
with or without FCS 10% for 2 hours.
Proliferation
After incubation with methyl-β-cyclodextrin, with RPMI+
FCS or with RPMI (the last being used as a control for
RPMI+FCS, considering that methyl-β-cyclodextrin is not
used in the medium with FCS), cells were collected,
washed and resuspended at 150,000 cells/ml in RPMI,
glutamin 2 mM, FCS 10%. Cells were seeded in triplicate
on 96-well microplates and incubated at 37°C and 5%
CO2. Proliferation was assessed by counting cells with a
cell coulter (Beckman Coulter, ZI model) at 24, 48 and 72
hours after seeding.
Caveolin-1 detection: western-blot
Cells were collected in late log-phase and washed twice in
PBS 150 mM and were resuspended in loading buffer
(urea 4 M, lauryl sulphate 3.8%, glycerol 20%, tris base 75
mM pH 6; β-mercaptoethanol 5%; bromophenol blue
5%) for 5 mn at 95°C. They were centrifuged at 12500 g,
4°C for 10 minutes, and 50 µg of extracted protein were
deposited per well on an 8% acrylamide gel. Migration
was performed in an electrophoresis buffer (TRIS base
125 mM; glycine 250 mM; lauryl-sulphate 0.1%, pH 8.1)
for 1 hour at 125 V with a size marker (Kaleidoscope
prestained standards Bio-rad). Protein was transferred on
a nitrocellulose membrane for 2 hours at 80 V and 4°C in
a transfer buffer (tris-base 48 mM; glycine 39 mM, SDS
0.037%, methanol 20%). Non-specific sites were blocked
with 1% milk (Regilait, skimmed milk, Saint-Martin-
Belle-Roche, France) in TBS 1X (tris-base 20 mM, NaCl
500 mM, and pH 7.5). The nitrocellulose membrane was
incubated for 1 hour at room temperature with 1 µg/ml
anti-caveolin 1 rabbit antibody (Tebu, France) and
washed three times for 10 minutes with TBS before
incubation for 1 hour at room temperature with goat anti-
rabbit and conjugate secondary antibody (1:3000). After
three washes in TBS for 10 minutes, staining was devel-
oped in a phosphatase alkaline buffer (NaHCO3 0.1 M;
MgCl2, 6H2O 1 mM) with tetrazolium nitro-blue 3% in
N,N-dimethylformamide 70% and bromo-4-chloro-3-
indolylphosphate p-toluidine 1% in N,N-dimethylforma-
mide 70% for 30 minutes at room temperature in the
dark.
Triton treatment
Cells were collected at the end of the log-phase, 4 days
after seeding, when ML were at a maximum, and washed
twice with 1 ml PBS 150 mM at 4°C. They were resus-
pended in paraformaldehyde (PFA) 3% in PBS 150 mM
for 30 minutes at 4°C and washed twice with 1 ml PBS
150 mM at 4°C to be resuspended in triton X-100 1% in
PBS 150 mM at 4°C for 30 minutes. Cells or triton-insol-
uble fractions were collected and washed for NMR exper-
iments at 25°C.
Sphingomyelinase treatment
After triton treatment, cells were collected, washed with
PBS 150 mM and treated for 35 mn at 37°C with 0.5 units
of sphingomyelinase. Cells were washed as described for
NMR experiments at 25°C.
NMR analysis
Cells were washed twice in 1 ml PBS 150 mM, twice in
PBS/D2O, centrifuged at 250 g and counted. Then, 107
cells were resuspended in 400 µl PBS/D2O before transfer
to a 5-mm Shigemi NMR tube. Experiments were per-
formed without rotation, and the ?analysed cell pellet was
maintained in the coil volume in the Shigemi NMR tube.Cancer Cell International 2005, 5:2 http://www.cancerci.com/content/5/1/2
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The NMR proton spectra of whole cells were obtained at
25°C on a Unity Inova spectrometer (Varian, France)
working at 500 MHz. One-dimensional runs were per-
formed by accumulating 128 transients of 90° pulse with
2 s relaxation time. The signal from the residual water was
suppressed by the presaturation technique, by using 0.03
mW irradiation for 2 s. Acquisition time was 1.34 s on
16K data points, corresponding to a spectral width of 6
kHz. The Fourier transform was applied without zero-fill-
ing using an exponential window multiplication function
corresponding to 1 Hz line broadening. The resonances
were integrated after automatic baseline correction. Two-
dimensional COSY runs were performed with 2K data
points in the F2 direction and 256 data points in the F1
direction. The two-dimensional Fourier transformation
was applied after zero filling to 512 data points in the F1
direction with a sine-bell function in both directions.
Each run consisted of a one-dimensional acquisition and
a two-dimensional COSY spectrum. Peak assignments
were based on data from the literature. The peak areas
were measured by manual integration with the Bruker
WINNMR software using a manual tangential baseline
correction for each peak, and the assigned peak areas were
normalized to the creatine peak area. The following reso-
nances were integrated: methyl group (CH3 at 0.9 ppm),
methylene group (CH2 at 1.3 ppm), choline N-trimethyl
group (N+(CH3)3 at 3.2 ppm) and creatine (CH3 at 3.05
ppm). The values obtained for the different treatments of
the two cells lines were compared by ANOVA analysis fol-
lowed by a Student-Neumann-Keuls test for group-to-
group comparison. P < 0.05 was considered as a signifi-
cant value.
NMR proton spectra of PFA or triton- or SMase-treated
cells were acquired at 500 MHz and 25°C on a Bruker
Advance DMX500 spectrometer (Bruker, Wissembourg,
France). The runs consisted of a 1D acquisition with sim-
ilar parameters as the previous 1D spectra, and the spec-
trum analysis was performed as previously with Bruker
WINNMR software.
The possible contribution of lactate to the 1.3 ppm signal
was eliminated by analysing 2D Cosy spectra in whole
cells, which resolved the resonances of lactate from fatty
acid chains. In fixed cells, we calculated the ratio of the
double-bond signal (CH = CH at 5.4 ppm) to CH2 peak
area. As both groups belong to fatty acyl chains, this ratio
remained constant since lactate did not significantly con-
tribute to the increase of the CH2 signal [1].
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Tris(hydroxymethyl)-1,3-propanediol; TBS: TRIS buffer
Saline; PFA: paraformaldehyde; COSY: correlated-spec-
troscopy; CH3: methyl; CH2: methylene; N(CH3)3: N-tri-
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